I've noticed that this is your first question about many drug companies mentioned on this board—e.g. #msg-127822905 is another instance. Not saying this is a bad thing!
Yes, I just recently came across these new names and they all kind of share some similarities to me. I generally like to try and follow up on names that seem like they could be good risk-rewards at current valuation but require a bit more DD. Always appreciate more help on the latter. ; )